The momentum behind psychedelic policy reform has surged over the past five years—especially within state legislatures. With over 220 bills introduced across 38 states and D.C. since 2020, the field is evolving rapidly. But sustained progress requires a clearer understanding of what’s working—and what’s not.
Sam Chapman
Panel on regulatory obstacles in psychedelic therapy research: Leaders from the industry discuss challenges with policymakers and predict future developments in the field.
Tadeusz Hawrot, Natasia Poinsatte, Nicole Howell
State programs' equity, adverse event management, community tensions, integration with mental health system, microdosing, and indigenous community respect are key topics discussed in the video.
Rebecca Martinez, Jonathan Treem, Tracey Tee
Executive Director Patty Salazar discusses Colorado's Natural Medicine Health Act.
Patty Salazar, Joshua White
Visionaries in Colorado and Oregon are shaping new psychedelic eco-systems by teaching, educating, and building businesses and nonprofits. Dreams are becoming reality in these emerging landscapes.
Jamie Beachy, Steve Elfrink, Martha Hammel, Nate Howard, Meaghan Len Richmond, Barine Majewska
Psilocybin service center facilitator discusses ceremonies and natural medicines in Colorado and Oregon's new state frameworks for participation in natural medicine practices.
William Wildcat Coakee, Sean McAllister, Dave Kopilak
Leaders of Oregon and Colorado campaigns discuss the historic creation of state frameworks for psychedelic healing, detailing the journey, current status, and future directions. Total words: 26
Kevin Matthews, Joshua Kappel
Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences
Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison
Panel experts discuss insurance coverage requirements for wide accessibility of psychedelic therapy, addressing what payors will need to support the treatments.
Elliot Marseille, Dan Grossman, Sherry Rais, Leslie Nylund
Indigenous communities are key to the emerging psychedelic industry but often see little benefit. How can companies ensure their inclusion and fair share in the growing market? Join the conversation.
Jeeshan Chowdhury, David Heldreth, Julia Mande
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.